Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 1

Status

Recruiting 2Active not recruiting 2

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Head & Neck 4Thoracic 1Gastrointestinal 1

Conditions

Pancreatic Neoplasms 23Triple Negative Breast Neoplasms 9Lung Neoplasms 8Neoplasm Metastasis 7Carcinoma, Non-Small-Cell Lung 7Breast Neoplasms 7Parkinson Disease 4, Autosomal Dominant Lewy Body 5Squamous Cell Carcinoma of Head and Neck 4Neoplasms 4Head and Neck Neoplasms 3Colorectal Neoplasms 3Sarcoma 2Recurrence 2Rectal Neoplasms 2Gallbladder Neoplasms 2Colonic Neoplasms 2Carcinoma, Pancreatic Ductal 2Biliary Tract Neoplasms 2Adenocarcinoma 2Small Cell Lung Carcinoma 1Sarcoma, Ewing 1Salivary Gland Neoplasms 1Rhabdomyosarcoma 1Resectable Pancreatic Cancer 1Pancreatic Adenocarcinoma 1Osteosarcoma 1Non-Small Cell Lung Cancer Metastatic 1Non Small Cell Lung Cancer NSCLC 1Neoplasms, Basal Cell 1Metastatic Pancreatic Ductal Adenocarcinoma 1

Interventions

pembrolizumab 66Cisplatin 40Carboplatin 25Cetuximab 23Magnetic Resonance Spectroscopy 19Paclitaxel 18Nivolumab 17Specimen Handling 16Radiotherapy, Intensity-Modulated 16Radiotherapy 14Docetaxel 13Platinum 121,2-diaminocyclohexaneplatinum II citrate 11Fluorouracil 9Taxes 8Biopsy 8atezolizumab 6cemiplimab 5Surgical Procedures, Operative 5Radiation 5Ipilimumab 5(225)Ac-DOTA-c(RGDyK) 5dostarlimab 4Standard of Care 4Immunoglobulin G 4Immune Checkpoint Inhibitors 4Cyclophosphamide 4Bevacizumab 4Albumin-Bound Paclitaxel 4toripalimab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Squamous Cell Carcinoma of Head and Neck × Albumin-Bound Paclitaxel × 90 days × Clear all
NCT07601737 2026-05-22

Nimotuzumab Combined With PD-1 Inhibitors and Chemotherapy in the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Phase 2 Recruiting
182 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT02270814 2026-05-05

CACTUX

Washington University School of Medicine

Phase 2 Active not recruiting
74 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT02495896 2026-04-29

Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors

University of Southern California

Phase 1 Active not recruiting
61 enrolled
GastrointestinalHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Gallbladder Neoplasms, Pancreatic Neoplasms

NCT07423078 2026-04-13

WOLF

University of Pittsburgh

Phase 2 Recruiting
87 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Neoplasm Metastasis, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡